Details of the Drug

General Information of Drug (ID: DMQ8AD4)

• Drug Name: OSSM-001

Indication

Disease Entry	ICD 11	Status	REF
Crohn disease	DD70	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DAD62Z

References

• [1] ClinicalTrials.gov (NCT05407766) A Phase I Safety Study of Allogeneic Bone Marrow Derived MSCs for Refractory Perianal Fistulizing Crohn's Disease. U.S.National Institutes of Health.